Cite
HARVARD Citation
Dörner, T. et al. (2020). Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Lupus science & medicine. 7 (1), p. . [Online].